USANA Health Sciences Inc (USNA)

Return on assets (ROA)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands 42,030 54,342 55,082 61,942 63,788 59,817 63,399 65,264 69,350 76,875 89,276 108,353 116,505 135,814 138,990 128,733 124,664 115,789 109,505 102,906
Total assets US$ in thousands 748,193 671,308 631,419 629,275 632,757 601,148 602,680 605,533 596,549 556,063 557,959 572,919 577,740 578,946 591,449 584,512 640,887 577,532 512,151 473,750
ROA 5.62% 8.09% 8.72% 9.84% 10.08% 9.95% 10.52% 10.78% 11.63% 13.82% 16.00% 18.91% 20.17% 23.46% 23.50% 22.02% 19.45% 20.05% 21.38% 21.72%

December 31, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $42,030K ÷ $748,193K
= 5.62%

The return on assets (ROA) for USANA Health Sciences Inc has shown a declining trend over the past few years. Starting at a healthy level of 21.72% as of March 31, 2020, the ROA gradually decreased to 5.62% by December 31, 2024.

A high ROA indicates that the company is efficiently generating profits from its assets. The declining ROA suggests that USANA Health Sciences Inc may be experiencing challenges in generating earnings relative to its asset base.

It is essential for the company to closely monitor and manage its asset utilization and profitability in order to improve its ROA and ensure long-term financial sustainability. Continued analysis and strategic actions may be necessary to reverse the downward trend in ROA and improve overall financial performance.